Patients with and without rheumatoid arthritis benefit equally from preoperative epoetin-α treatment

Acta Orthopaedica

Volumn 77, Issue 4, 2006, Pages 677-683

  Slappendel, Robert ^a   Weber, Eric W G ^a   Hémon, Yves J M ^b   Mähler, Stefan ^a   Dalén, Tore ^c   Rouwet, Eduard F A M ^d   Van Os, Johannes J ^e   Vosmaer, Alexander ^f   Van Der Ark, Peter D ^a  

^a Sint Maartenskliniek ^*  (Netherlands)

^b HÔPITAL SAINTE MARGUERITE   (France)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^d Streekziekenhuis Koningin Beatrix   (Netherlands)

^e Sittard Geleen Heerlen   (Netherlands)

^f IKAZIA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ARTHROPATHY; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUCED DISEASE; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NATURALISTIC INQUIRY; NAUSEA; OPEN STUDY; PARESTHESIA; PATIENT CARE; PREOPERATIVE TREATMENT; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; THROMBOSIS; URINARY TRACT INFECTION;

AGED; ARTHRITIS, RHEUMATOID; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; EPOETIN ALFA; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; IRON; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; SPINAL DISEASES; TREATMENT OUTCOME;

EID: 33747653648     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.1080/17453670610012782     Document Type: Article

References (19)

1. Adamson J. Perisurgical use of epoetin alfa in orthopedic surgery patients. Semin Hematol (Suppl 2) 1996; 33: 55-8.
2. Bierbaum B E, Callaghan J J, Galante J O, Rubash H E, Tooms R E, Welch R B. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg (Am) 1999; 81 (1): 2-10.
3. Cimmino M A, Parisi M, Querci G, Ghio R, Accardo S. Intravenous iron is effective in treating the anaemia of rheumatoid arthritis and is not associated with flares of synovitis. Clin Rheumatol 1997; 16: 215-6.
4. Drueke T B. Modulating factors in the hematopoietic response to erythropoietin. Am J Kidney Dis (4 suppl 1) 1991; 18: 87-92.
5. Goldberg M A, McCutchen J W, Jove M, Di Cesare P, Friedman R J, Poss R, et al. A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery. Am J Orthop 1996; 25: 544-52.
6. Innerhofer P, Luz G, Spotl L, Hobisch-Hagen P, Schobersberger W, Fischer M, et al. Immunologic changes after transfusion of autologous or allogeneic buffy coat-poor versus white cell-reduced blood to patients undergoing arthroplasty. I. Proliferative T-cell responses and the balance of helper and suppressor T cells. Transfusion 1999; 39: 1089-96.
7. Kendall R, Wasti A, Harvey A, Hill J, Chapman C, Norfolk D R, Pullar T. The relationship of haemoglobin to serum erythropoietin concentrations in the anaemia of rheumatoid arthritis: the effect of oral prednisolone. Br J Rheumatol 1993; 32: 204-8.
8. Landers D F, Hill G E, Wong K C, Fox I J. Blood transfusion-induced immunomodulation. Anesth Analg 1996; 82: 187-204.
9. Marx J J M. Iron and infection: competition between host and microbes for a precious element. Best practice & Research Clinical Haematology 2002; 15: 411-26.
10. Matsui H, Shiraishi N, Yasuda T, Nezuka T. The effects of recombinant human erythropoietin on autologous blood donation in rheumatoid arthritis patients with anaemia. Clin Exp Rheumatol 1999; 17: 69-74.
11. Miller C B, Jones R J, Piantadosi S, Abeloff M D, Spivak J L. Decreased erythropoietin response in patients with anemia of cancer. New Engl J Med 1990; 322: 1689-92.
12. Nordström D, Lindroth Y, Marsal L, Hafström I, Henrich C, Rantapää-Dahlqvist S, et al. Availability of iron and degree of inflammation modifies the response to recombinant human erythropoietin when treating anemia of chronic disease in patients with rheumatoid arthritis. Rheumatol Int 1997; 17: 67-73.
13. Olijhoek G, Megens J G, Musto P, Nogarin L, Gassmann-Mayer C, Vercammen E, Hayes-Licitra SA. Role of oral versus IV iron supplementation in the erythropoietic response to rHuEPO: a randomized, placebo-controlled trial. Transfusion 2001; 41: 957-63.
14. Peeters H R M, Jongen-Lavrencic M, Vreugdenhil G, Swaak A J G. Effect of recombinant erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial. Ann Rheum Dis 1996; 55: 739-44.
15. Peeters H R, Jongen-Lavrencic M, Bakker C H, Vreugdenhil G, Breedveld F C, Swaak A J. Recombinant human erythropoietin improves health-related quality of life in patients with rheumatoid arthritis and anaemia of chronic disease; utility measures correlate strongly with disease activity measures. Rheumatol Int 1999; 18: 201-6.
16. Rosencher N, Kerkkamp H, Macheras G, Munuera L M, Menichella G, Barton D M, et al. Orthopedic surgery transfusion hemoglobin European overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003; 43(4): 459-69.
17. Slappendel R, Dirksen R, Weber E W G, Van der Schaaf D B. An algorithm to reduce allogenic red blood cell transfusions for major orthopedic surgery. Acta Orthop Scand 2003; 74 (5): 569-75.
18. Stivelman J C. Resistance to recombinant human erythropoietin therapy: a real clinical entity? Semin Nephrol (1 suppl 2)1989; 9: 8-11.
19. Weber E W G, Slappendel R, Hémon Y, Mähler S, Dalén T, Rouwet E F A M, et al. Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery. The European Epoetin alfa Surgery Trial (EEST). Blood transfusions and postoperative recovery, general. Eur J Anaesthesiol 2005; 22: 249-57.